(2R,3R/2S,3S)-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-LEUCYL-GLYCYL]-3-ETHOXYCARBONYL-AZIRIDINE-2-CARBOXYLIC-ACID
Compound with spectra: 1 NMR
![(2R,3R/2S,3S)-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-LEUCYL-GLYCYL]-3-ETHOXYCARBONYL-AZIRIDINE-2-CARBOXYLIC-ACID](/api/compound/JcykFBv8MfS.png?ph=true&h=300&w=458 "(2R,3R/2S,3S)-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-LEUCYL-GLYCYL]-3-ETHOXYCARBONYL-AZIRIDINE-2-CARBOXYLIC-ACID")
| SpectraBase Compound ID | JcykFBv8MfS |
|---|---|
| InChI | InChI=1S/2C19H31N3O8/c2*1-7-29-17(27)14-13(16(25)26)22(14)12(23)9-20-15(24)11(8-10(2)3)21-18(28)30-19(4,5)6/h2*10-11,13-14H,7-9H2,1-6H3,(H,20,24)(H,21,28)(H,25,26)/t2*11?,13-,14-,22?/m10/s1 |
| InChIKey | CSQVTBVILHWHFP-KHEJKKAWSA-N |
| Mol Weight | 858.94 g/mol |
| Molecular Formula | C38H62N6O16 |
| Exact Mass | 858.42223 g/mol |
| Enantiomer InChIKey | CSQVTBVILHWHFP-WBSUXYMFSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(2R,3R/2S,3S)-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-PHENYLALANYL]-AZIRIDINE-2,3-DICARBOXYLIC-ACID
N-(ALPHA)-(TERT.-BUTOXYCARBONYL)-O-(TERT.-BUTYL)-GLUTAMYLSERYLLEUCINE-TERT.-BUTYLESTER
N-[N-(TERT.-BUTOXYCARBONYL)-L-PHENYLALANYL-L-SERYL]-O-TERT.-BUTYL-L-VALIN
Benzyloxycarbonyl-leucyl-(p-benzyloxy)phenylalanine, t-butyl ester
TERT.-BUTYLOXYCARBONYL-L-LEUCYL-L-PROLYL-METHYLESTER
N-TERT.-BUTOXYCARBONYL-L-THREONYL-L-LEUCYL-L-SERYL-L-ALANINE-ALLYLESTER;BOC-THR-LEU-SER-ALA-OALL
METHYL-N-(BENZYLOXYCARBONYL)-PHENYLALANYLLEUCYLLEUCINE
N-[N-(TERT.-BUTOXYCARBONYL)-L-VALYL-L-SERYL]-O-TERT.-BUTYL-L-PHENYLALANIN
N-[N-(TERT.-BUTOXYCARBONYL)-L-PHENYLALANYL-(BETA-O-ACETYL)-L-SERYL]-O-TERT.-BUTYL-L-ALANIN
L-Leucine, N-[N-[N-[(phenylmethoxy)carbonyl]-L-leucyl]-L-isoleucyl]-, methyl ester
| Title | Journal or Book | Year |
|---|---|---|
| aziridinyl peptides as inhibitors of cysteine proteases: Effect of a free carboxylic acid function on inhibition | Bioorganic & Medicinal Chemistry | 2000 |